Volume 17, Number 7—July 2011
Dispatch
Melioidosis, Phnom Penh, Cambodia
Table 1
Antimicrobial drug | MIC, µg/mL |
MIC50 | MIC90 | Breakpoints, µg/mL |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0.38 | 0.5 | 0.75 | 1 | 1.5 | 2 | 3 | 4 | 6 | 8 | S | R | ||||||
Meropenem | 3 | 29 | 16 | 1 | 3 | 2 | – | – | – | – | 0.5 | 1.5 | <4 | >16 | |||
Doxycycline† | – | 13 | 19 | 18 | 3 | 1 | – | – | – | – | 0.75 | 1 | <4 | >16 | |||
Ceftazidime† | – | 2 | 0 | 18 | 25 | 7 | 2 | – | – | – | 1.5 | 2 | <8 | >32 | |||
Amoxicillin/ clavulanic acid | – | 1 | 0 | 13 | 30 | 7 | 2 | 1 | – | – | 1.5 | 2 | <8 | >32 | |||
Chloramphenicol | – |
– |
– |
– |
1 |
1 |
0 |
17 |
16 |
12 |
6 | 8 | <8 | >32 | |||
0.032 |
0.038 |
0.047 |
0.064 |
0.094 |
0.125 |
0.19 |
0.25 |
0.38 |
0.75 |
1 |
1.5 |
3 |
|||||
Sulfamethoxazole/ trimethoprim | 3 | 1 | 7 | 12 | 5 | 9 | 4 | 7 | 1 | 1 | 3 | 1 | 0 | 0.125 | 0.75 | <2 | >4 |
*MICs determined by Etest (AB Biodisk, Solna, Sweden). MIC50, MIC for 50% of isolates; MIC90, MIC for 90% of isolates; S, susceptible; R, resistant; –, no isolates with this MIC.
†53 isolates included.
Page created: August 15, 2011
Page updated: August 15, 2011
Page reviewed: August 15, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.